Jose Morato-Rodriguez
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 47 publications
Comparing [18F]FDG-positron emission tomography and breast magnetic resonance imaging to predict pathological complete response and 3-year invasive disease-free survival in HER2-positive early breast cancer patients: an unplanned exploratory analysis of the PHERGain trial.
Journal: ESMO open
Published: February 28, 2025
Neoadjuvant therapy in HER2-positive breast cancer and interim PET - Authors' reply.
Journal: Lancet (London, England)
Published: January 10, 2025
Atezolizumab plus paclitaxel and bevacizumab as first-line treatment of advanced triple-negative breast cancer: the ATRACTIB phase 2 trial.
Journal: Nature medicine
Published: November 05, 2024
Olaparib monotherapy in advanced triple-negative breast cancer patients with homologous recombination deficiency and without germline mutations in BRCA1/2: The NOBROLA phase 2 study.
Journal: Breast (Edinburgh, Scotland)
Published: July 29, 2024
Profiling the gut and oral microbiota of hormone receptor-positive, HER2-negative metastatic breast cancer patients receiving pembrolizumab and eribulin.
Journal: Microbiome research reports
Published: July 11, 2024
Correlation between trophoblast cell-surface antigen-2 (Trop-2) expression and pathological complete response in patients with HER2-positive early breast cancer treated with neoadjuvant docetaxel, carboplatin, trastuzumab, and pertuzumab.
Journal: Breast cancer research and treatment
Published: December 26, 2023
The impact of decision tools during oncological consultation with lung cancer patients: A systematic review within the I3LUNG project.
Journal: Cancer medicine
Published: November 10, 2023
3-year invasive disease-free survival with chemotherapy de-escalation using an 18F-FDG-PET-based, pathological complete response-adapted strategy in HER2-positive early breast cancer (PHERGain): a randomised, open-label, phase 2 trial.
Journal: Lancet (London, England)
Published: September 29, 2023
Adipose Tissue Protects against Hepatic Steatosis in Male Rats Fed a High-Fat Diet plus Liquid Fructose: Sex-Related Differences.
Journal: Nutrients
Published: July 26, 2023
Last Updated: 09/26/2026